Grey‑market premiums for the upcoming IPOs of Wakefit and Corona Remedies have climbed as much as 18–31% ahead of their subscription opening. Wakefit’s IPO (₹1,288 crore) is priced at ₹185–195 per share, while Corona Remedies’ offer (₹655 crore) comes at ₹1008–1062 per share. The rising GMP signals strong pre‑IPO demand and growing market optimism about their potential listing gains. Investors remain alert as the IPOs go live Monday.